Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ADARx, adult, AdvaMed, advocacy, Amal, approx, Aptevo, arisen, army, Ashkelon, Ashot, ASV, Bachelor, Baran, Becerra, Beladev, Botzer, branch, Britain, BROMIDE, cardiorespiratory, catalyst, CBS, CGU, channel, Cidofovir, clarified, Coach, coaching, COAGADEX, Comverse, conciliation, confirmatory, congressional, contraindicated, correctly, crime, Cyrillic, CYTGOM, Cytotec, deceased, departure, deployed, detention, elucidating, energy, ESG, EVP, eye, fading, fast, faster, FBC, FDIC, fear, FISCHER, folding, foot, footprint, Franchise, Frutarom, gas, Geneva, Gilead, globe, GLYCOPYRRONIUM, Goldfarb, Gorelik, grew, hereunder, Histadtrut, Houston, HR, Infinya, Intellia, invaded, invoice, invoiced, IRA, Iraq, irritation, Junior, Kamad, KPMG, KR, lawyer, Liron, mathematical, McKesson, Microbiology, mid, Moldova, Montevideo, nationwide, NDA, neglected, Neumologia, notably, obtrusive, ODDITY, Ofil, oil, OPTN, overturned, PAS, pattern, paused, payer, pharmacy, PhRMA, poor, prematurely, PRIME, Prothya, Quebec, reap, redistribution, reevaluated, reevaluation, Reichman, relocation, Reshef, resiliency, retention, SE, Seligman, seminal, serial, Shalpharm, shined, Silicon, smallest, Sociedad, spotlight, stakeholder, Supreme, SVB, TICI, traditional, TRIMBOW, truthful, TSA, turmoil, Tyto, unanimously, unbilled, unlimited, unquoted, unremedied, unstable, Uri, Uruguaya, Uvalde, Valley, Valneva, vi, vigorously, voiced, waste, Wave, won
Removed:
add, Amnir, anti, Argon, Ariella, autoimmune, Ayalon, bearing, begun, Bonsity, book, branded, briefly, bundled, Carmel, cessation, China, chose, circumvent, Claude, close, clotting, cohort, collaborated, complement, constitutionality, correction, dimar, directing, diversify, Donald, Dr, dysfunction, Eli, extending, FITE, fracture, Galam, GP, grossed, guaranteed, Hadera, Harvard, harvest, headquarter, histology, implanted, infused, injectable, injected, instilled, investigator, IRI, Johnson, Kam, Lanka, Lilly, locating, marketable, Markmann, Metal, MGH, Michal, millstone, MMA, Modernization, modifying, Morgan, Novolog, Obama, Omrix, Oramed, organism, ORMP, owed, Oxygen, Paper, perfusion, Phoenix, pledged, preliminary, prevalent, protective, Raban, recurring, refractory, refundable, Renal, repeal, restatement, retrospective, Sri, Stanley, stockholder, straight, surgery, sweeping, Telecom, Telkoor, teriparatide, thoracic, thought, transform, Trump, unaudited, underwriting, unsatisfied, vowed, Welch, Wire, yielded, younger
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 4.23 Compensation Policy for Executive Officers
- 4.24 Compensation Policy for Directors
- 4.25 Kamada LTD. 2011 Israeli Share Award Plan
- 4.37 Amended and Restated Manufacturing Services Agreement Dated As of September 28, 2017, by and Between Emergent Biosolutions, Inc. and Aptevo Therapeutics Inc. (Assumed by Kamada LTD.)
- 4.38 Contract Manufacturing, Services and Supply Agreement Dated November 29, 2022, by and Between Kamada LTD. and Prothya Biosolutions Belgium
- 4.39 Supplemental Letter Agreement Dated As of July 4, 2022, by and Between Kamada LTD. and Tuteur S.a.c.i.f.i.a.
- 4.40 2ND Amendment to the Distribution Agreement, Dated As of February 22, 2023, by and Between Kamada LTD. and Tuteur S.a.c.i.f.i.a.
- 8.1 Subsidiaries of the Registrant
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 15.1 Consent of Ernst & Young Global, Independent Registered Public Accounting Firm
- Download Excel data file
- View Excel data file
Associated KMDA transcripts
KMDA similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos 333-192720, 333-207933, 333-215983, 333- 222891, 333-233267 and 333-265866) pertaining to the 2011 Israeli Share Plan of Kamada Ltd. of our reports dated March 15, 2023, with respect to the consolidated financial statements of Kamada Ltd. and the effectiveness of internal control over financial reporting of Kamada Ltd. included in this Annual Report (Form 20-F) for the year ended December 31, 2022.
/s/ KOST FORER GABBAY & KASIERER | |
KOST FORER GABBAY & KASIERER | |
A member of Ernst & Young Global | |
March 15, 2023 | |
Tel Aviv, Israel |